New Key Statistics Module, Z-Score and F-Score
NAS:CRNX Key Ratios
| Market Cap $ M | 5,000.41 |
| Enterprise Value $ M | 4,192.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.23 |
| Price/Sales | 3,851.41 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -3.73 |
| Beneish M-Score | -3.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -11.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.67 |
| EV-to-EBITDA | -13.77 |
| PEG | -- |
| Shares Outstanding M | 92.74 |
| Net Margin (%) | -26,747.83 |
| Operating Margin % | -29,525.22 |
| Pre-tax Margin (%) | -26,747.83 |
| Quick Ratio | 16.38 |
| Current Ratio | 16.38 |
| ROA % (ttm) | -33.66 |
| ROE % (ttm) | -38.33 |
| ROIC % (ttm) | -351.41 |
| Dividend Yield % | -- |
| Altman Z-Score | 27.53 |
CRNX Number of Guru Trades
CRNX Volume of Guru Trades
Gurus Latest Trades with NAS:CRNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRNX is held by these investors
Total 2
Crinetics Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CRNX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers